Xiuli L. Ju

No. 107 Wenhua West Road
Jinan, 250012, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Transcription factor zinc fingers and homeoboxes protein 2 (ZHX2) drives CRABP1 targeting to strengthen retinoic acid sensitivity and potentiate therapeutic response in neuroblastoma.

Transcription factor zinc fingers and homeoboxes protein 2 (ZHX2) drives CRABP1 targeting to strengthen retinoic acid sensitivity and potentiate therapeutic response in neuroblastoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 10, 2025

Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations.

Landscape of Somatic Mutations in a Large Cohort of Chinese Patients With Immune Dysregulations.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 18, 2025

Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.

Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.

Journal: Haematologica

Published: September 10, 2025

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

A low- versus standard-dose regimen as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood

Published: July 23, 2025

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Low- vs standard-dose regimens as induction for pediatric AML: a multicenter, randomized noninferiority trial.

Journal: Blood

Published: July 23, 2025

Intratracheal administration of mesenchymal stem cells ameliorates hyperoxia-induced bronchopulmonary dysplasia by inhibiting NLRP3 inflammasome activation: the critical role of Aldh1a2.

Intratracheal administration of mesenchymal stem cells ameliorates hyperoxia-induced bronchopulmonary dysplasia by inhibiting NLRP3 inflammasome activation: the critical role of Aldh1a2.

Journal: Stem cell research & therapy

Published: May 21, 2025

Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL.

Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL.

Journal: Blood

Published: April 29, 2025

Risk factors for DIC in paediatric APL: Insights from the CCLG-APL 2016 study.

Risk factors for DIC in paediatric APL: Insights from the CCLG-APL 2016 study.

Journal: British journal of haematology

Published: January 10, 2025

A multicenter single-arm clinical study of Chinese children's cancer group-acute promyelocytic leukemia-2017 (CCCG-APL-2017) protocol.

A multicenter single-arm clinical study of Chinese children's cancer group-acute promyelocytic leukemia-2017 (CCCG-APL-2017) protocol.

Journal: Signal transduction and targeted therapy

Published: December 02, 2024

Accessibility of and Barriers to Long-Term Follow-Up Care for Childhood Cancer Survivors.

Accessibility of and Barriers to Long-Term Follow-Up Care for Childhood Cancer Survivors.

Journal: JAMA network open

Published: October 17, 2024

Transcriptomic and proteomic sequencing unveils the role of vitamin D and metabolic flux shifts in the induction of human hepatic organoids.

Transcriptomic and proteomic sequencing unveils the role of vitamin D and metabolic flux shifts in the induction of human hepatic organoids.

Journal: Stem cell research & therapy

Published: August 01, 2024

Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial.

Efficacy and safety of recombinant human thrombopoietin for the treatment of chronic primary immune thrombocytopenia in children and adolescents: A multicentre, randomized, double-blind, placebo-controlled phase III trial.

Journal: British journal of haematology

Published: July 08, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026